Literature DB >> 25062523

An overview of clinical tools used to assess neonatal abstinence syndrome.

Susan Orlando1.   

Abstract

Several clinical tools have been developed to quantify the severity of withdrawal signs and symptoms exhibited by infants born to substance-using mothers. Scores from the systematic assessments are used to guide treatment of infants with moderate to severe clinical signs. This article provides an overview of published assessment tools developed for infants with neonatal abstinence syndrome. Nurses caring for infants at risk for neonatal abstinence syndrome should be knowledgeable about the tools used to evaluate these infants and guide their treatment. The ideal assessment tool should be published and include item definitions and a protocol for administering the tool. Nurses need education and training to achieve competency and interobserver reliability in the use of a selected tool. Tool-specific materials should be used to standardize training and improve accuracy in assessments. Competent and knowledgeable nurses play a critical role in improving outcomes for infants with neonatal abstinence syndrome.

Entities:  

Mesh:

Year:  2014        PMID: 25062523     DOI: 10.1097/JPN.0000000000000043

Source DB:  PubMed          Journal:  J Perinat Neonatal Nurs        ISSN: 0893-2190            Impact factor:   1.638


  8 in total

1.  Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System.

Authors:  E Gomez-Pomar; A Christian; L Devlin; K T Ibonia; V A Concina; H Bada; P M Westgate
Journal:  J Perinatol       Date:  2017-04-06       Impact factor: 2.521

2.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

3.  Opioid treatment for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-07

4.  Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.

Authors:  Enrique Gomez Pomar; Loretta P Finnegan; Lori Devlin; Henrietta Bada; Vanessa A Concina; Katrina T Ibonia; Philip M Westgate
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

5.  Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay.

Authors:  Lori A Devlin; Timothy Lau; Paula G Radmacher
Journal:  Front Pediatr       Date:  2017-10-10       Impact factor: 3.418

Review 6.  Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics.

Authors:  Philip M Westgate; Enrique Gomez-Pomar
Journal:  Front Pediatr       Date:  2017-09-20       Impact factor: 3.418

7.  Development and application of a primer and reference assessment tool for neonatal abstinence syndrome: A phase I pilot study.

Authors:  Ekaterina Burduli; Crystal Lederhos Smith; Phoebe Tham; Maureen Shogan; Ron Kim Johnson; Sterling M McPherson
Journal:  Contemp Clin Trials Commun       Date:  2019-12-03

8.  Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain).

Authors:  Miriam Moreno-Ramos; Mercedes Sánchez-Barba; Rubén García Sánchez; José Antonio Mirón-Canelo; Veronica González-Nuñez
Journal:  Children (Basel)       Date:  2021-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.